Whole exome sequencing (WES) with in silico gene panel analysis
Clinical Report (Download a sample report here)
~3-6 weeks*
For detailed information about the sample requirements, please consult our clinical sample requirements page.
For detailed information about the sample requirements, please consult our clinical sample requirements page.
Hereditary cancer is caused by inherited genetic variants passed down through families, which increases the risk of developing certain cancers, typically accounting for 5-10% of all cancer cases. Common hereditary cancers include breast, ovarian, and colorectal cancer. Hereditary cancers are often linked to inherited variants in genes that help control cell growth and division. Well-known examples are the BRCA1/BRCA2 genes for breast and ovarian cancer, and the APC gene for Familial Adenomatous Polyposis (FAP) of the colon.
This panel may be an option when the patient has high risk of having or developing an hereditary cancer. Hereditary cancer is suspected when there is family history of the same cancer or related forms of cancer, early age of onset, multiple cancers in an individual, bilateral (cancers occurring in both paired organs - e.g., both breasts, both kidneys) or multifocal cancers (multiple tumours in the same organ), rare or unusual tumourswhich are strongly associated with hereditary syndromes. This panel includes the genes more frequently associated with hereditary cancer. For a more comprehensive analysis, we recommend using our Comprehensive Hereditary Cancer Panel which contains all genes included on this panel and more.